Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α-Synuclein in Parkinson’s disease: causal or bystander?
Peter Riederer, Daniela Berg, Nicolas Casadei, et al.
Journal of Neural Transmission (2019) Vol. 126, Iss. 7, pp. 815-840
Closed Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis
Alireza Soltani Khaboushan, Niloufar Yazdanpanah, Nima Rezaei
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1724-1743
Closed Access | Times Cited: 153
Detection of neuron-derived pathological α-synuclein in blood
Annika Kluge, Josina Bunk, Eva Schaeffer, et al.
Brain (2022) Vol. 145, Iss. 9, pp. 3058-3071
Open Access | Times Cited: 148
The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
Adina N. MacMahon Copas, Sarah F. McComish, Jean M. Fletcher, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 126
Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4176-4176
Open Access | Times Cited: 89
Probiotics for Parkinson’s Disease
Parisa Gazerani
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4121-4121
Open Access | Times Cited: 127
Diet in Parkinson's Disease: Critical Role for the Microbiome
Aeja Jackson, Christopher B. Forsyth, Maliha Shaikh, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 107
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Isabel Úbeda‐Bañón, Daniel Saiz‐Sánchez, Alicia Flores‐Cuadrado, et al.
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 96
The gut microbiome in Parkinson's disease: A culprit or a bystander?
Ali Keshavarzian, Phillip A. Engen, Salvatore Bonvegna, et al.
Progress in brain research (2020), pp. 357-450
Closed Access | Times Cited: 85
Parkinson’s disease treatment: past, present, and future
John D. Elsworth
Journal of Neural Transmission (2020) Vol. 127, Iss. 5, pp. 785-791
Open Access | Times Cited: 75
Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's Disease
Hilary Grosso Jasutkar, Stephanie Oh, M. Maral Mouradian
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 207-237
Open Access | Times Cited: 66
Lewy body disease or diseases with Lewy bodies?
Kateřina Menšíková, Radoslav Matěj, Carlo Colosimo, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 54
The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches
Alice Drobny, Susy Prieto Huarcaya, Jan Philipp Dobert, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 7, pp. 119243-119243
Open Access | Times Cited: 51
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 5, pp. 611-625
Open Access | Times Cited: 34
Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson’s disease
Júlio César Claudino dos Santos, Leandro Freitas Oliveira, Felipe Micelli Noleto, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2611-2614
Open Access | Times Cited: 33
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
Peter Riederer, Toshiharu Nagatsu, Moussa B. H. Youdim, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 5, pp. 627-646
Open Access | Times Cited: 31
Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction
Masaru Tanaka, László Vécsei
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1367-1387
Open Access | Times Cited: 9
Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
Jeswinder Sian‐Hülsmann, Peter Riederer
Journal of Neural Transmission (2024)
Open Access | Times Cited: 8
Alpha Synuclein Connects the Gut-Brain Axis in Parkinson’s Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology
Eva Schaeffer, Annika Kluge, Martina Böttner, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 62
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Peter Riederer, Camelia Monoranu, Sabrina Strobel, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 10, pp. 1577-1598
Open Access | Times Cited: 54
The structural heterogeneity of α-synuclein is governed by several distinct subpopulations with interconversion times slower than milliseconds
Jiaxing Chen, Sofia Zaer, Paz Drori, et al.
Structure (2021) Vol. 29, Iss. 9, pp. 1048-1064.e6
Open Access | Times Cited: 43
Ion Channel Dysfunction in Astrocytes in Neurodegenerative Diseases
Sijian Wang, Biyao Wang, Dehao Shang, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 32
Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
Makoto Naoi, Wakako Maruyama, Masayo Shamoto‐Nagai
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11059-11059
Open Access | Times Cited: 31
Aquaporin-4 and Parkinson’s Disease
К. В. Лапшина, И. В. Екимова
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1672-1672
Open Access | Times Cited: 6
Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease
Makoto Naoi, Wakako Maruyama, Masayo Shamoto‐Nagai
Journal of Neural Transmission (2020) Vol. 127, Iss. 2, pp. 131-147
Closed Access | Times Cited: 49
Does Gut Microbiota Influence the Course of Parkinson’s Disease? A 3-Year Prospective Exploratory Study in de novo Patients
Roberto Cilia, M. Piatti, Emanuele Cereda, et al.
Journal of Parkinson s Disease (2020) Vol. 11, Iss. 1, pp. 159-170
Closed Access | Times Cited: 39
Page 1 - Next Page

Scroll to top